QPS is a global contract research organization that provides services across the drug development spectrum from discovery to late stage clinical development. It has facilities in the US, Europe, and Asia with over 750 employees. QPS offers integrated services including DMPK, toxicology, bioanalysis, translational medicine, and clinical development. It prides itself on its experienced staff and linearly integrated core competencies to efficiently guide clients' compounds from discovery through regulatory approval.
4. History 1994 Bio-Kinetic Clinical Applications (BKCA) founded 1995 QPS (Delaware) founded 1999 Xendo Drug Development founded 2004 QPS Taiwan founded >>> 2008 QPS acquired BKCA to establish QPS Bio-Kinetic >>> 2010 QPS acquired Xendo Drug Development to establish QPS Netherlands >>> 2010 QPS acquired CTPS to establish QPS-CTPS Taiwan >>> 2011 QPS acquired Qualitix to establish QPS-Qualitix Taiwan >>> >>> >>> >>> 1984 Center of Toxicology and Preclinical Sciences (CTPS)/DCB founded >>> 1990 2000 2011 1997 Genovate/Qualitix founded >>> 2011 QPS acquired Bioserve to establish QPS-Bioserve India >>> 2005 Bioserve founded >>>
The foundation of QPS was established in 1995 as Quest.
QPS Europe has a state of the art 25,000 ft 2 GLP compliant bioanalytical facilities. The laboratory is in operations since 1999 and has a real international customer base serving the majority of the top 10 Pharma companies and the top 5 Biotech companies. The services consists of Chromatography and Mass Spectrometry; Biochemistry and Immunology and in the competence centre Elemental Spectrometry QPS Europe offers ICP-MS and LC-ICP-MS.